Top Markets
#1 Songbird Songbird +9.45%
#2 Prom Prom +4.62%
#3 pipedog pipedog +4.04%
#4 TENDIES TENDIES +3.18%
#5 BORA BORA +3.18%
#6 Bitway Bitway +2.76%
#7 PulseX PulseX +2.66%
#8 Wrapped Pulse Wrapped Pulse +2.65%
#9 The Grays Currency The Grays Currency +2.46%
#10 o1.exchange o1.exchange +2.37%
Coin of the day
Songbird Songbird
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Lepu Biopharma Co., Ltd. Lepu Biopharma Co., Ltd.

Lepu Biopharma Co., Ltd.

2157
Kedudukan dalam Saham #9736
Lepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise,... Lepu Biopharma Co., Ltd. operates as a biopharmaceutical enterprise, concentrating its efforts on the development of innovative oncology therapies. It maintains a broad pipeline of cancer-fighting products primarily aimed at the Chinese market. The company's therapeutic candidates encompass a range of modalities, including cutting-edge antibody-drug conjugates (ADCs), oncolytic virus treatments, and diverse immunotherapies. Among its immuno-oncology offerings are HX008 (an anti-PD-1 mAb) and LP002 (an anti-PD-L1 mAb). The ADC portfolio features MRG003 (targeting EGFR), MRG002 (targeting HER2), MRG001 (targeting CD20), MRG004A (targeting TF), and CMG901 (targeting CLDN18.2). Additionally, Lepu Biopharma is advancing the oncolytic virus CG0070, along with various combination therapies such as HX008+OH2, LP002+OH2, and HX008+LP002. Founded in 2018, the company is headquartered in Shanghai, China.
Harga Saham
$0.53025422
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$956.81M
Perubahan (1 hari)
0.61%
Perubahan (1 tahun)
-52.36%
Negara
CN
Perdagangan Lepu Biopharma Co., Ltd. (2157)

Kategori

Healthcare
Pendapatan untuk Lepu Biopharma Co., Ltd. (2157)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Lepu Biopharma Co., Ltd., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Lepu Biopharma Co., Ltd. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH